Skip to main content
SpringerLink
Log in

Drug treatment of borderline personality disorders

  • New Drugs and Therapeutics
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. New AS, Trestman RL, Siever LJ, et al. The pharmacotherapy of borderline personality disorder. CNS Drugs 1994; 2(5): 347–54

    Article  Google Scholar 

  2. Soloff PH. Is there any drug treatment of choice for the borderline patient? Acta Psychiatr Scand 1994; 89 Suppl. 379: 50–55

    Article  Google Scholar 

  3. Gardner DL, Cowdry RW. Pharmacotherapy of borderline personality disorder: a review. Psychopharmacology Bulletin 1989; 25(4): 515–23

    PubMed  CAS  Google Scholar 

  4. Markowitz PJ, Calabrese JR, Schulz SC, et al. Fluoxetine in the treatment of borderline and schizotypal personality disorders. Am J Psychiatry 1991; 148(8): 1064–7

    Google Scholar 

  5. Cornelius JR, Soloff PH, Perel JM, et al. A preliminary trial of fluoxetine in refractory borderline patients. J Clin Psychopharmacol 1991; 11(2): 116–20

    Article  PubMed  CAS  Google Scholar 

  6. Salzman C, Wolfson AN, Schatzberg A, et al. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J Clin Psychopharmacol 1995; 15(1): 23–9

    Article  PubMed  CAS  Google Scholar 

  7. Kavoussi RJ, Liu J, Coccaro EF. An open trial of sertraline in personality disordered patients with impulsive aggression. J Clin Psychiatry 1994; 55: 137–141

    PubMed  CAS  Google Scholar 

  8. Parsons B, Quitkin FM, McGrath PJ, et al. Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depression. Psychopharmacology Bulletin 1989; 25(4): 524–34

    PubMed  CAS  Google Scholar 

  9. Soloff PH, Cornelius J, George A, et al. Efficacy of phenelzine and haloperidol in borderline personality disorder. Arch Gen Psychiatry 1993; 50: 377–85

    Article  PubMed  CAS  Google Scholar 

  10. Cowdry RW, Gardner DL. Pharmacotherapy of borderline personality disorder: alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. Arch Gen Psychiatry 1988; 45: 111–9

    Article  PubMed  CAS  Google Scholar 

  11. Martindale. The Extra Pharmacopoeia, 30th ed. London; The Pharmaceutical Press, 1993

    Google Scholar 

  12. British National Formulary No. 28. London: The Pharmaceutical Press, 1994

  13. Soloff PH, George A, Swami Nathan R, et al. Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response. J Clin Psychopharmacol 1989; 9(4): 238–46

    Article  PubMed  CAS  Google Scholar 

  14. Brinkley JR, Beitman BD, Friedel RO. Low-dose neuroleptic regimens in the treatment of borderline patients. Arch Gen Psychiatry 1979; 36: 319–26

    Article  PubMed  CAS  Google Scholar 

  15. Leone NF. Response of borderline patients to loxapine and chlorpromazine. J Clin Psychiatry 1982; 43: 148–50

    PubMed  CAS  Google Scholar 

  16. Frankenburg FR, Zanarini MC. Clozapine treatment of borderline patients: a preliminary study. Comprehensive Psychiatry 1993; 34(6): 402–5

    Article  PubMed  CAS  Google Scholar 

  17. Sheard M, Marini J, Bridges C, et al. The effect of lithium on impulsive aggressive behaviour in man. Am J Psychiatry 1976; 133: 1409–13

    PubMed  CAS  Google Scholar 

  18. Stein G. Physical treatments of the personality disorders. Current Opinion in Psychiatry 1994; 7: 129–36

    Article  Google Scholar 

  19. Gardner DL, Cowdry RW. Positive effects of carbamazepine on behavioural dyscontrol in borderline personality disorder. Am J Psychiatry 1986; 143: 519–22

    PubMed  CAS  Google Scholar 

  20. De la Fuente JM, Lotstra F. A trial of carbamazepine in borderline personality disorder. European Neuropsychopharmacology 1994; 4: 479–86

    Article  PubMed  Google Scholar 

  21. Gardner DL, Cowdry RW. Development of melancholia during carbamazepine treatment in borderline personality disorder. J Clin Psychopharmacol 1986; 6(4): 236–9

    Article  PubMed  CAS  Google Scholar 

  22. Cornelius JR, Soloff PH, Perel JM, et al. Continuation pharmacotherapy of borderline personality disorder with haloperidol and phenelzine. Am J Psychiatry 1993; 150: 1843–8

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Drug treatment of borderline personality disorders. Drugs Ther. Perspect 5, 9–12 (1995). https://doi.org/10.2165/00042310-199505090-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199505090-00004

Keywords

Search

Navigation